Andrew Hedin

Andrew Hedin

Director/Board Member at Nido Biosciences, Inc.

39 year
Finance
Health Technology
Consumer Services

Profile

Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.

Andrew Hedin active positions

CompaniesPositionStart
Private Equity Investor 2015-06-30
Director/Board Member -
All active positions of Andrew Hedin

Former positions of Andrew Hedin

CompaniesPositionEnd
KYMERA THERAPEUTICS, INC. Director/Board Member 2021-06-15
Private Equity Analyst 2013-07-29
TSCAN THERAPEUTICS, INC. Director/Board Member -
Corporate Officer/Principal -
See the detail of Andrew Hedin's experience

Training of Andrew Hedin

University of Pennsylvania Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Hedin's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
KYMERA THERAPEUTICS, INC.

Health Technology

TSCAN THERAPEUTICS, INC.

Health Technology

Private companies4

Finance

Finance

Finance

Health Technology

See company connections